Genomic Vision 

0
0
+€0,00+0% 00:00 Oggi

Statistiche

Massimo giornaliero
-
Minimo del giorno
-
Massimo 52S
-
Min 52S
-
Volume
-
Vol. medio
-
Cap. di mercato
0
Rapporto P/E
-
Rendimento da dividendo
-
Dividendo
-

Concorrenti

Questo elenco è un'analisi basata su eventi di mercato recenti. Non è una raccomandazione di investimento.

Informazioni

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
Mostra di più
CEO
Mr. Aaron Bensimon
Dipendenti
27
Paese
Francia
ISIN
FR0011799907
WKN
000A110TM

Quotazioni

0 commenti

Condividi i tuoi pensieri

Domande frequenti

Qual è il simbolo azionario di Genomic Vision?▼
A seconda della borsa, il simbolo dell’azione può variare. Ad esempio, alla borsa Boerse Muenchen le azioni di Genomic Vision sono negoziate con il simbolo G09.MU.
Quanti dipendenti ha Genomic Vision?▼
Al 1 novembre 2026, l'azienda conta 27 dipendenti.
In quale settore opera Genomic Vision?▼
Genomic Vision opera nel settore Salute e Benessere.
Quando Genomic Vision ha completato lo split azionario?▼
Genomic Vision non ha effettuato alcuno split di recente.
Dove si trova la sede di Genomic Vision?▼
La sede di Genomic Vision si trova a Bagneux, Francia.